Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation ; volume:112 ; number:8 ; day:25 ; month:3 ; year:2023 ; pages:1087-1095 ; date:8.2023
Clinical research in cardiology ; 112, Heft 8 (25.3.2023), 1087-1095, 8.2023
- Creator
-
Wallbach, M.
Valentova, M.
Schroeter, M. R.
Alkabariti, A.
Iraki, I.
Leha, A.
Tampe, D.
Hasenfuß, G.
Zeisberg, M.
Hellenkamp, K.
Koziolek, M. J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-023-02184-6
- URN
-
urn:nbn:de:101:1-2023102516232188269750
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wallbach, M.
- Valentova, M.
- Schroeter, M. R.
- Alkabariti, A.
- Iraki, I.
- Leha, A.
- Tampe, D.
- Hasenfuß, G.
- Zeisberg, M.
- Hellenkamp, K.
- Koziolek, M. J.
- SpringerLink (Online service)
Other Objects (12)
Chronische Herzinsuffizienz mit reduzierter Auswurffraktion (HFrEF)
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
Intrarenal Doppler ultrasonography reflects hemodynamics and predicts prognosis in patients with heart failure
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Vericiguat : innovativer Wirkansatz zur Therapie der Herzinsuffizienz (HFrEF) nach Dekompensation
Vericiguat : neue Option zur Therapie der Herzinsuffizienz (HFrEF) nach Dekompensation
Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021
Differential impacts of body composition on oxygen kinetics and exercise tolerance of HFrEF and HFpEF patients
Chronische Herzinsuffizienz mit reduzierter Auswurffraktion (HFrEF)
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
Intrarenal Doppler ultrasonography reflects hemodynamics and predicts prognosis in patients with heart failure
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Vericiguat : innovativer Wirkansatz zur Therapie der Herzinsuffizienz (HFrEF) nach Dekompensation
Vericiguat : neue Option zur Therapie der Herzinsuffizienz (HFrEF) nach Dekompensation
Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021
Differential impacts of body composition on oxygen kinetics and exercise tolerance of HFrEF and HFpEF patients
Chronische Herzinsuffizienz mit reduzierter Auswurffraktion (HFrEF)
Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
Different determinants of exercise capacity in HFpEF compared to HFrEF
Intrarenal Doppler ultrasonography reflects hemodynamics and predicts prognosis in patients with heart failure
From Mouse Models to Patients: A Comparative Bioinformatic Analysis of HFpEF and HFrEF
Vericiguat : innovativer Wirkansatz zur Therapie der Herzinsuffizienz (HFrEF) nach Dekompensation
Vericiguat : neue Option zur Therapie der Herzinsuffizienz (HFrEF) nach Dekompensation
Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance
Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF
Patients with HFpEF and HFrEF have different clinical characteristics but similar prognosis: a retrospective cohort study
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021